MRC1 and cancer: Furthermore, predictive testing for family members of women with a pathogenic variant in genes such as the MMR genes, BRCA1/2, RAD51C, RAD51D and BRIP1 provides options for reducing their cancer risk, with screening, surgery or chemoprevention.